Five Biotech Stocks Showing Significant Momentum

Written by Emily J. Thompson, Senior Investment Analyst

ENTO%

ARQT-1.93%

HOTH-3.7%

Source: Benzinga

Updated: Aug 28 2025

0mins

Source: Benzinga

Biotechnology Stocks on the Rise: Several biotechnology stocks have shown strong bullish activity this week, indicating potential for short-term gains, with ADC Therapeutics, Arcutis Biotherapeutics, Cellectis, Entero Therapeutics, and Hoth Therapeutics leading the momentum rankings.
Top Performers: ADC Therapeutics (ADCT) leads with a momentum ranking of 89.87%, gaining 4.55% in the last five sessions and 61.00% year-to-date. Other notable performers include Arcutis Biotherapeutics (ARQT) at 86.54% and Cellectis (CLLS) at 88.58%.
Market Trends: The momentum rankings highlight rapid price movements compared to sector peers, often driven by catalysts such as clinical trial results or regulatory approvals, although momentum may not always be sustainable.
Mixed Market Performance: In premarket trading, major ETFs like SPDR S&P 500 ETF Trust (SPY) showed slight gains while Invesco QQQ Trust ETF (QQQ) experienced a minor decline, reflecting mixed market conditions.

About the author

Emily J. Thompson

Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.

Five Biotech Stocks Showing Significant Momentum

About the author

Top News

Oil Firms Cautious on Venezuela Investment Push

GM Reports $7.1 Billion Charge Amid EV Shift

Stock Market Wraps 2025 with Double-Digit Gains

Novo Nordisk's Weight-Loss Pill Approval: Key Impacts

Related Articles

Bitcoin, Ethereum, and Solana Poised for Comeback in 2026

Nvidia Projects Data Center Market to Reach $4 Trillion by 2030

Sigh Up to Get Intellectia Insights

How did the company's recent strategic decisions impact its latest financial performance?

Can you explain the factors behind the recent changes in the company's stock price?

What are the expected impacts of current market trends on the company's future growth?

Based on the latest earnings report, what are the company's forecasted revenues for the next quarter?

How does the company's performance compare to its main competitors in the same sector?

People Also Watch